Nabi Biopharmaceuticals Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings Limited
09. November 2012 07:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 9, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today the effectiveness of its six-to-one reverse stock split (the "Reverse Stock Split") of Nabi...
Nabi Biopharmaceuticals Announces Third Quarter 2012 Financial Results
08. November 2012 17:20 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the three-month period ended September 30, 2012. The...
Nabi Biopharmaceuticals Announces Special Cash Dividend
05. November 2012 08:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that Nabi's Board of Directors declared a special cash dividend in the aggregate of approximately...
The Board of Nabi Biopharmaceuticals Establishes Ratio for Reverse Stock Split
25. Oktober 2012 16:55 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its board of directors (the "Board") has established a ratio of one share-for-every six...
Nabi Biopharmaceuticals Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota Stockholders
23. Oktober 2012 17:47 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today the results of the reconvened special meeting of Nabi stockholders held on October 22, 2012 (the...
Nabi Biopharmaceuticals Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings Limited
19. Oktober 2012 07:45 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 19, 2012 (GLOBE NEWSWIRE) -- Nabi today announced that, if the proposed business combination transaction between Nabi Biopharmaceuticals (Nasdaq:NABI) and Biota Holdings Limited...
Nabi Biopharmaceuticals Announces Results of NicVAX(R) Phase II Study in Combination With Varenicline
17. Oktober 2012 07:45 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 17, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that the phase II study of NicVAX® (Nicotine Conjugate Immunotherapeutic) in combination...
Nabi Biopharmaceuticals Sets Record Date for Cash Dividend
16. Oktober 2012 16:22 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Nabi today announced that Nabi's Board of Directors has set October 26, 2012 as the record date with respect to the cash dividend to be paid in...
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceutical Stockholders Support Amended Transaction With Biota Holdings Limited at October 22nd Reconvened Special Meeting
16. Oktober 2012 08:55 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nadsaq:NABI) ("Nabi") today announced that the two major independent proxy advisory firms, Institutional Shareholder Services...
Nabi Biopharmaceuticals Announces Adjournment of Special Meeting of Stockholders Until October 22, 2012
24. September 2012 15:50 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its Special Meeting of Stockholders scheduled for September 24, 2012 has been adjourned to...